Beverly, MA – According to filings with the U.S. Securities and Exchange Commission, seqWell is raising $8,000,000.00 in new funding. Sources indicate as part of senior management President, Joseph Mellor played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About seqWell
seqWell was created to revolutionize NGS library prep to unlock the full potential of todays DNA sequencing instruments. Our plexWell platform is a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. plexWell has wide-ranging impact on applications from synthetic biology, targeted sequencing and single-cell analysis to low and high depth sequencing of human, plant, animal and microbial genomes. In addition to plexWell, seqWell is also developing library prep methods for reagent-based approaches for long-molecule phasing and read linking.

To learn more about seqWell, visit http://www.seqwell.com/

Contact:
Joseph Mellor, President
617-379-1589
https://www.linkedin.com/in/joseph-mellor-30380687/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved